NES
CHTP

New England Securities’s CHELSEA THERAPEUTICS INT'L LTD CHTP Stock Holding History

New England Securities’s Portfolio CHTP Stock Details CHTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-2,850
Closed -$16K – 1921
2014
Q1 		$16K Buy
2,850
+2,650
+1,325% +$13.3K 0.01% 938
2013
Q4 		$1K Hold
200
– – ﹤0.01% 1602
2013
Q3 		$1K Hold
200
– – ﹤0.01% 1598
2013
Q2 		$0 Buy
+200
New +$404 ﹤0.01% 1434

Other funds holding CHTP

Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

New England Securities's CHTP Position: Q2 2014 in Review

New England Securities sold out of CHELSEA THERAPEUTICS INT'L LTD (CHTP) in Q2 2014, closing a stake of 2,850 shares — an estimated $16K sold.

New England Securities first reported a position in CHTP in Q2 2013 and held it in 4 quarters. The position peaked at $16K in Q1 2014. 6 funds tracked by Wall St. Rank hold CHTP as of Q2 2014.

  • New England Securities reported no remaining CHELSEA THERAPEUTICS INT'L LTD position as of Q2 2014 after selling out during the quarter.
  • New England Securities sold 2,850 CHELSEA THERAPEUTICS INT'L LTD shares in Q2 2014, an estimated $16K.
  • New England Securities first reported a position in CHELSEA THERAPEUTICS INT'L LTD in Q2 2013 and held it in 4 quarters.
  • New England Securities's CHELSEA THERAPEUTICS INT'L LTD position peaked at $16K in Q1 2014.
  • 6 funds tracked by Wall St. Rank held CHELSEA THERAPEUTICS INT'L LTD as of Q2 2014.

Based on New England Securities's 13F filing for Q2 2014, filed 4 Aug 2014.